Zobrazeno 1 - 10 of 26 pro vyhledávání: '"Marija Dencic, Fekete"'
2
Several different cytogenetic clones arising during treatment of Philadelphia positive chronic myeloid leukemia with tyrosine kinase inhibitors lead to the progression into Philadelphia negative acute myeloid leukemia
Autor: Vesna Djordjevic, Biljana Todoric-Zivanovic, Danijela Lekovic, Jelica Jovanovic, Andrija Bogdanovic, Ljubomir Jakovic, Marija Dencic-Fekete
Publikováno v: Vojnosanitetski Pregled, Vol 78, Iss 1, Pp 114-118 (2021)
Introduction. Additional karyotype abnormalities in the Philadelphia-positive (Ph+) clone can emerge during the progression of chronic myeloid leukemia (CML) and are of-ten associated with the resistance to treatment with tyrosine kinase inhibitors (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd4a482f92e62cbc444f881695b1b7b9
https://doi.org/10.2298/vsp180723010d
Zobrazit plný text záznamu
3
Significance of cytogenetic-risk categories and refined international prognostic scoring system for overall survival in primary myelofibrosis: A single-center experience
Autor: Vesna Djordjevic, Gradimir Jankovic, Andrija Bogdanovic, Jelica Jovanovic, Marija Dencic-Fekete, Ivan Soldatovic
Publikováno v: Vojnosanitetski Pregled, Vol 77, Iss 5, Pp 516-524 (2020)
Vojnosanitetski pregled (2020) 77(5):516-524
Background/Aim. Primary myelofibrosis (PMF) is a chronic, malignant hematological disease characterized by a leucoerythroblastic blood picture, anisopoikilocytosis teardrop- shaped erythrocytes, different degrees of bone marrow fibrosis and hepatospl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ec49d7e089908a922a7050719b8a6cf
http://www.doiserbia.nb.rs/img/doi/0042-8450/2020/0042-84501800117D.pdf
Zobrazit plný text záznamu
4
Prediction of optimal cytogenetic responses at 6 and 12 months in patients with chronic myeloid leukemia in chronic phase treated with imatinib
Autor: Violeta, Milosevic, Maja Perunicic, Jovanovic, Zoran, Bukumirić, Vesna, Djordjevic, Jelica, Jovanovic, Marija Dencic, Fekete, Danijela, Lekovic, Andrija, Bogdanovic
Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(3)
Imatinib mesylate transformed the treatment and paradigms of chronic myeloid leukemia. European LeukemiaNet (ELN) group has defined specific treatment milestones with an optimal outcome to be achieved in patients.In a retrospective cohort study, we e
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7c8e0b096cb7f9b1d574e076a42b47bb
https://pubmed.ncbi.nlm.nih.gov/34268974
Zobrazit plný text záznamu
5
P-161: Ultra-high-risk prognostic significance of double and triple hit myeloma
Autor: Marija Dencic Fekete, Biljana Mihaljevic, Jelica Jovanovic, Darko Antic, Jelena Jelicic, Marko Mitrovic, Jelena Bila, Zoran Bukumiric, Aleksandra Sretenovic, Teodora Peric
Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 21:S123-S124
Background Association of any of 2 or ≥3 specific high-risk chromosomal abnormalities (HR-CA: t(4;14), t(14;16), t(14;20) and +1q21) in multiple myeloma (MM) characterizes double or triple hit MM. Aims The aim of study was to evaluate prognostic si
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::483d547b163bdb96cc744f7a18a8e29b
https://doi.org/10.1016/s2152-2650(21)02288-6
Zobrazit plný text záznamu
6
Comparative analysis of International Prognostic Index for chronic lymphocytic leukemia, progression-risk score, and MD Anderson Cancer Center 2011 score: A single center experience
Autor: Biljana Mihaljevic, Vojin Vukovic, Teodora Karan-Djurasevic, Marija Dencic-Fekete, Natasa Milic, Sonja Pavlovic, Darko Antic, Tatjana Kostic, Natasa Tosic, Irena Marjanovic, Tijana Dragovic-Ivancevic, Vladislava Djurasinovic
Publikováno v: Srpski arhiv za celokupno lekarstvo (2021) 149(7-8):415-421
Srpski Arhiv za Celokupno Lekarstvo, Vol 149, Iss 7-8, Pp 415-421 (2021)
Introduction/Objective. Prognostication of chronic lymphocytic leukemia (CLL) has been substantially improved in recent times. Among several prognostic models (PMs) focused on the prediction of time to first treatment (TTFT), progression-risk score (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b87c5aa73d5e4858a6c4712832d47bd
http://scindeks.ceon.rs/article.aspx?artid=0370-81792107415M
Zobrazit plný text záznamu
7
Myelodysplastic/myeloproliferative neoplasm with t(2;11)(P21;Q23)del(5) (Q22;Q33) but without mixed-lineage leukemia (MLL) rearrangement
Autor: Mirjana Gotic, Marija Dencic-Fekete, Natasa Colovic, Dragana Stamatovic, Danijela Lekovic
Publikováno v: Vojnosanitetski pregled (2021) 78(2):251-254
Vojnosanitetski Pregled, Vol 78, Iss 2, Pp 251-254 (2021)
Introduction. Myelodysplastic/myeloproliferative neoplasms represent a group of rare hematologic malignancies with concomitant characteristics of two different disorders. There are cytopenias and cytoses with dysplastic morphology in the circulating
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eea6f105a77eed941fad6e6e3f2518f9
http://scindeks.ceon.rs/article.aspx?artid=0042-84502102251Q
Zobrazit plný text záznamu
8
Rapid progression to Richter’s syndrome in patient with chronic lymphocytic leukemia and near-triploid karyotype
Autor: Marija Dencic-Fekete, Tatjana Terzic, Ljubomir Jakovic, Vladislava Djurasinovic, Djurasevic Karan, Milica Radojkovic, Sonja Pavlovic, Andrija Bogdanovic
Publikováno v: Vojnosanitetski pregled. :60-60
Introduction. The presence of aneuploidy in patients with chronic lymphocytic leukemia (CLL), except trisomy 12, is quite uncommon. The frequency of hyperdiploidy or near-tetraploidy ocurrs in 1-3% of the CLL patients and usually confer poor prognosi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::02666a27e229fc24ee766263c37cbec2
https://doi.org/10.2298/vsp211111060d
Zobrazit plný text záznamu
9
The predictive value of morphological findings in early diagnosis of acute myeloid leukemia with recurrent cytogenetic abnormalities
Autor: Natasa Tosic, Andrija Bogdanovic, Ljubomir Jakovic, Sonja Pavlovic, Vesna Djordjevic, Marija Dencic-Fekete, Vesna Knezevic, Tatjana Terzic, Nada Kraguljac-Kurtovic
Publikováno v: Leukemia Research. 75:23-28
This study explores cytomorphologic features and their predictive role for early identification of acute myeloid leukemia (AML) with morphological distinctive recurrent cytogenetic abnormalities (RCA): t(15;17), t(8;21) and inv(16)/t(16;16). We retro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8039dab2f2fd3810b13bd67fe0906de8
https://doi.org/10.1016/j.leukres.2018.10.017
Zobrazit plný text záznamu
10
The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients
Autor: Goran Trajkovic, Jelena Jelicic, Jelena Bila, Aleksandra Sretenovic, Darko Antic, Biljana Mihaljevic, Marija Dencic Fekete, Maja Perunicic Jovanovic
Publikováno v: Oncology Research and Treatment. 40:616-620
Background: The Revised International Staging System (R-ISS) has recently been introduced as a comprehensive prognostic score for multiple myeloma (MM). Validation of the R-ISS in patients treated outside of clinical trials is the focus of current in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbf4b0aee38ae6c7f5bac896016b8bfe
https://doi.org/10.1159/000478935
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje